Table 2 Assumed hospitalization rates in the no-test and test scenario (based on data in German women participating in the PROGNOSIS study)
From: Economic assessment of the use of the sFlt-1/PlGF ratio test to predict preeclampsia in Germany
| Â | Distribution between categories | Assumed hospitalization rate |
|---|---|---|
No-test scenario | Â | 44.6% |
Test scenario | ||
 sFlt-1/PlGF ratio ≥ 85 at weeks 20 + 0–33 + 6, or ≥ 110 from week 34 onwards | 19.60% | 70.0% |
 sFlt-1/PlGF ratio > 38 − < 85 at weeks 20 + 0–33 + 6, or > 38 − < 110 from week 34 onwards | 16.20% | 57.6% |
 sFlt-1/PlGF ratio ≤ 38 | 64.20% | 1.5% |